Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

JRNYS vs Medivive

JRNYS
Graded #88

Higher grade

vs+12.300000000000004
Medivive
Graded #343

Lower grade

The verdict

JRNYS takes it — 71.7/100 to 59.4/100.

JRNYS grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. JRNYS is a telehealth weight-loss program built around branded GLP-1 medications, including semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), dulaglutide, and liraglutide (Saxenda), paired…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueJRNYS +8
78
70
Dose & formulationJRNYS +30
70
40
Clinical oversightJRNYS +21
84
63
Labs & monitoringMedivive +3
61
64
FulfillmentJRNYS +4
65
61
Contract termsEven
55
55
JRNYS · left barMedivive · right bar

The numbers

MetricJRNYSMedivive
WeighScore71.7/10059.4/100
GradeCC
Scorecard rank#88#343
Semaglutide$89/mo (plus a separate fee, brand-name)Not disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
JRNYS

Graded #88 · C

Strengths

  • Branded GLP-1s (Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda)
  • Insured members may pay ~$25/mo for medication after deductible
  • Includes 1-on-1 coaching at every membership tier
  • Led by CMO Dr. Henry Legere with strong academic credentials
  • Transparent membership pricing ($89-$169/mo)

Where it loses points

  • Medication cost separate from membership; self-pay varies
  • Best value requires commercial insurance coverage
  • Compounded option not disclosed; brand-focused
  • State availability not published
Medivive

Graded #343 · C

Strengths

  • Compounded semaglutide and tirzepatide with providers licensed in all 50 states
  • No insurance required; one-stop for GLP-1 plus TRT, NAD+ and longevity care
  • Medication filled through a licensed pharmacy

Where it loses points

  • Monthly pricing not published; disclosed only after an AI intake
  • No legal entity or named pharmacy disclosed
  • Service states are not individually listed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard